- Home
- HVT vs ALDX Comparison
HVT vs ALDX Comparison
Compare HVT & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | ALDX |
|---|---|---|
| Founded | 1885 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.1M | 317.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | HVT | ALDX |
|---|---|---|
| Price | $22.96 | $4.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 60.1K | ★ 747.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.66% | N/A |
| EPS Growth | N/A | ★ 40.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.36 | N/A |
| Revenue Next Year | $8.75 | $123.43 |
| P/E Ratio | $22.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.01 | $1.18 |
| 52 Week High | $27.67 | $7.19 |
Technical Indicators
Market Signals| Indicator | HVT | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 31.86 | 42.75 |
| Support Level | $21.97 | $4.74 |
| Resistance Level | $23.74 | $5.70 |
| Average True Range (ATR) | 0.93 | 0.29 |
| MACD | -0.33 | -0.04 |
| Stochastic Oscillator | 13.12 | 1.69 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.